Grifols’ Annus Horribilis Has Analysts and Short Sellers Divided
Spanish drugmaker Grifols SA is poised for its worst year on record, but some analysts aren’t ready yet to give…
6,683€
-0,71%
Echtzeit-Aktienkurs GRIFOLS SA PREF. B EO-,05
Bid:
Ask:
Nachrichten zur GRIFOLS SA PREF. B EO-,05 Aktie
SEC Drops Probe Into Gotham Over Report on Grifols’ Accounts
The US dropped its investigation into General Industrial Partners LLP, the parent company of Gotham City Research, which accused drug…
The High-Powered Lawyer Behind the Grifols Group’s Rise and Fall
For hedge fund Mason Capital Management LLC, much of what ails Grifols SA can be laid at the door of…
Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?
On Wednesday, Grifols SA (NASDAQ:GRFS) said it ended discussions with Brookfield Capital Partners (UK) Limited about a potential acquisition. This…
Grifols In Talks to Refinance Debt, Credit Line, CEO Says
The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a…
Brookfield Is Said to Plan to Walk Away From Grifols Bid
Brookfield Asset Management Ltd. is preparing to walk away from a plan to acquire Grifols SA over disagreements on valuation…
Banks to Pitch Roughly €11 Billion Buyout Debt Deal for Grifols
Banks are getting ready to submit final offers to Brookfield Asset Management for a debt package of about €11 billion…
Brookfield to Request More Time for Grifols Due Diligence
Brookfield Asset Management will request more time to conduct due diligence on Grifols SA, as it seeks to take the…
Grifols Investor Group With 7.7% Holding Seeks Seat on Board
A group of Grifols SA investors including Flat Footed LLC, Mason Capital Management LLC and Sachem Head Capital Management LP…
Grifols Seeks Adviser to Help Deal With Minority Shareholders
Spanish drugmaker Grifols SA, the target of a short-seller attack earlier in the year, is seeking to hire an external…
Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’
Some large Grifols SA shareholders are increasing pressure on the Spanish blood plasma firm to seek a substantial premium in…
Brookfield Seeks Close to €10 Billion Debt for Grifols Bid
Brookfield Asset Management is asking banks to backstop up to €9.5 billion ($10.6 billion) of debt for its potential take-private…
Grifols’ New Auditor Discovers Non-Cash Accounting Discrepancy Linked to China Stake
Spain’s Grifols SA is set to report an unexpected accounting adjustment related to its stake in Shanghai RAAS, according to…
Grifols Shareholder Scranton Reported to Seek Loan from Oaktree
Scranton Enterprises, a major shareholder of Spanish pharmaceutical company Grifols SA, is in talks with Oaktree Capital Management for a…
Short Seller Gains on Grifols Bet That Tripped Elliott Spinout
A well-publicized short bet by General Industrial Partners on Spanish company Grifols SA helped the hedge fund earn double-digit gains…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - GRFS
NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical Report – Hagens Berman
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages GRFS American Depositary Receipt Investors with Substantial Losses to Contact Firm HAGENS BERMAN, NATIONAL…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - GRFS
NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Grifols’ Financials Have No Big Errors, Spanish Regulator Says
Spanish securities regulators said they didn’t find any big mistakes in Grifols SA’s financial reports, though the pharmaceutical company does…
Grifols Shares Jump as Auditor Greenlights Annual Accounts
Grifols SA shares rallied from multiyear lows after an auditor signed off on the annual accounts of the Spanish plasma…
Grifols Analysts Are Losing Faith After Disappointing Guidance
In the weeks following a short seller attack earlier this year, analysts mostly stood behind Spanish blood plasma firm Grifols…
GRFS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Grifols S.A. (NASDAQ: GRFS) Investors with Significant Losses to Contact the Firm
RADNOR, Pa., March 01, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…
Activists Load Up on Temenos, Grifols After Short Seller Reports
Some activist investors are doubling down on their bets on Temenos AG and Grifols SA after short-seller reports roiled the…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - GRFS
NEW YORK, Feb. 11, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - GRFS
NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Grifols Sues in NY Over Gotham City Short-Seller Report
Grifols SA sued Gotham City Research over a report alleging the company has overstated profit and misstated its accounting.…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - GRFS
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF
NEW YORK, Jan. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF
NEW YORK, Jan. 21, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - GRFS
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Grifols Shareholder Scranton Is Questioned by Spanish Regulators
Scranton Enterprises BV, the investment company at the center of a short-seller attack on Grifols SA, was asked by Spain’s…
ECB Asks Banks for Details About Exposure to Spain’s Grifols
The European Central Bank has asked some lenders to provide information on their exposure to Grifols SA, according to people…
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF
NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
Grifols Analyst Breaks Ranks With Peers After Short Seller Chaos
An analyst covering Grifols SA, the Spanish blood plasma company plunged into chaos after a recent short-seller report, has broken…
Grifols S.A. (GRFS) Plummets After Gotham City Research Questions Accounting – Hagens Berman
GRFS Investors with Substantial Losses Encouraged to Contact Hagens Berman, National Trial Attorneys GRFS Investors with Substantial Losses Encouraged to…
ROSEN, A LEADING LAW FIRM, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
Gotham Allegations ‘False,’ Grifols CEO Tells Investors
Grifols SA said allegations made by short seller Gotham City Research LLC that triggered the biggest single-day drop in its…
Grifols Faces Investor Scrutiny of Billionaire Family’s Control
Investors in Grifols SA are set to press the company on corporate governance issues and questions about the billionaire family…
Gotham City Owner Cuts Grifols Short Position After Plunge
The owner of Gotham City Research LLC, whose critical report sparked a record one-day stock selloff in Grifols SA, has…
Grifols S.A. (GRFS) Plummets After Gotham City Research Questions Accounting – Hagens Berman
GRFS Investors with Substantial Losses Encouraged to Contact Hagens Berman, National Trial Attorneys GRFS Investors with Substantial Losses Encouraged to…
GRFS Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Grifols, S.A. for Potential Securities Law Violations
We are investigating whether Grifols, S.A. has violated federal securities laws based on allegations in a report by Gotham City…
Short Seller Criticizes Grifols Accounting Practices
Spanish blood plasma firm Grifols SA tumbled after short seller Gotham City Research LLC published a report criticizing its financial reporting. …
Grifols Falls as Short Seller Gotham Criticizes Accounting
Shares and bonds of Spanish blood plasma firm Grifols SA tumbled after short seller Gotham City Research LLC published a…
Global Blood Group Typing Market Size To Worth USD 3.98 Billion by 2032 | CAGR of 8.4%
The Global Blood Group Typing Market Size was valued at USD 1.78 Billion in 2022. The Worldwide Blood Group Typing…
Grifols in Talks to Sell Part of RAAS Stake to China Merchants
Spanish plasma company Grifols SA is in advanced talks to sell part of its minority stake in Shanghai RAAS Blood…
Blood Screening Market revenue to hit USD 5.03 Billion by 2035, says Research Nester
Key blood screening market players include Abbott Laboratories, Grifols, S.A., Quotient Limited, Thermo Fisher Scientific Inc., BD, Ortho al Diagnostics,…
Grifols, S.A. (GRFS) Q3 2023 Earnings Call Transcript
…
Grifols S.A. reports Q3 results
…
Biotest AG setzt Ausrufezeichen. Squeeze Out Kandidat zeigt was in ihm steckt. Standhaft gebliebene Vorzugs-Aktionäre lachende Dritte?
"Biotest AG Vorzüge (ISIN: DE0005227235) setzt unter dem neuen Hauptaktionär Grifols S.A. weiterhin auf Expansion und auf den Erfolg des…
Albumin Market revenue to cross USD 10 Billion by 2035, says Research Nester
Prominent albumin market players include Apotex Inx., Octapharma AG, Bio Med International Pvt. Ltd., Baxter, Novozymes, Mitsubishi Tanabe Pharma America…